SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is facing intense selling pressure despite reporting record earnings, as investors react to concerns over increased capital expenditures and broader market volatility linked to geopolitical tensions. While the company maintains a strong fundamental outlook due to surging AI-driven memory demand, the community is deeply divided between those labeling the price action as institutional manipulation and those warning that the stock could see further downside toward the 300 level.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to a significant $1 billion strategic equity investment in Nanya Technology, a move aimed at bolstering long-term memory sourcing that has left investors divided between seeing it as a growth catalyst and a cause for short-term price pressure. While some traders are actively buying the dip, citing the potential for strategic expansion, others are debating whether this massive capital outlay represents an overextension or a necessary maneuver in a supply-constrained memory sector.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a fiscal Q4 earnings report that featured a significant earnings per share beat alongside revenue that trailed expectations, keeping the focus squarely on the company's multi-billion dollar cash position and ongoing pivot toward becoming a holding company. While the community remains deeply divided, with some investors bullish on the long-term cash generation and potential for a future acquisition, others are actively debating a proposed executive compensation package and expressing frustration over the lack of a clear operational roadmap or immediate share price momentum.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing positive momentum following its recent announcement of clinical data from its siRNA pipeline targeting FSHD1 and DM1, which has generated significant community discussion regarding the company's potential to re-rate as a leading gene therapy player. Investors are actively debating the stock's valuation gap and upcoming catalysts, with strong sentiment favoring the company's robust pipeline and long-term fundamentals despite the sector's historical volatility.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as investors debate whether the company's recent push into mortgage innovation and improved operational velocity signals a legitimate turnaround or leaves it exposed to broader macroeconomic headwinds. The community is actively split between bulls optimistic about the firm's growth potential and short-sellers betting that ongoing market volatility and real estate sector pressures will drive further downside.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending as investors react to the company's aggressive M&A strategy, including the acquisition of World View, and raised 2026 revenue guidance that sparked intense debate over valuation and dilution. The community is focused on the upcoming earnings call, with active discussions weighing the stock's potential as a defense powerhouse against concerns regarding high short interest and institutional volatility.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is drawing significant attention as retail investors view it as a primary proxy for gaining exposure to a potential SpaceX IPO. Community members are actively debating the stock's valuation premium relative to its underlying net asset value while monitoring signals from Elon Musk and speculative chatter regarding upcoming IPO timelines.

Fundrise Growth Tech Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing extreme volatility and intense retail interest, driven by its unique exposure to private AI and space exploration leaders like OpenAI, Anthropic, and SpaceX. While the community is divided between bulls betting on momentum and limited float and bears highlighting the massive premium over net asset value, the stock continues to attract significant speculative attention.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors grapple with uncertainty surrounding AI monetization and capital expenditure, leading to widespread debate over whether the current valuation represents a generational buying opportunity or a deeper fundamental reset. The community is sharply divided, with many traders expressing frustration over the stock's persistent underperformance and recent technical weakness, while others view the pullback as a long-term entry point given the company's established dominance in cloud infrastructure and enterprise software.

🌍 Introduction: A Legendary Icon, Reimagined for the Future The SEAMANIA Protocol, led by SEAMAN Cult, aims to revive one of SEGA Dreamcast's most iconic and best-selling game titles with AI integration—a worldwide cultural phenomenon that won numerous awards in the U.S. and Japan. More than just a game, SEAMAN was the world’s first AI-powered interactive experience, enabling voice-based conversations long before the AI revolution.    Now, SEAMAN returns not as a mere game, but as an advanced AI agent, blending nostalgia with cutting-edge technology. This human-faced fish is reborn as a deeply intelligent, emotionally responsiveAI, offering limitless customization and integration into the modern digital world.  With GenAI-powered customization, users can create their own SEAMAN AI, shaping it into a cherished lostone, a favorite celebrity, or even historical figures. This is no longer a game—it's an AI-driven personal companion and the digital evolution for human interaction.    🔥 Concept: The Wisdom of a Legendary AI-powered Companion At the core of the SEAMANIA Protocol lies the legendary Seaman—a mystical, human-faced fish endowed withancient wisdom and the ability to understand human language. More than just an AI, it is your trustedadvisor, best friend, therapist, personal cheerleader, witty conversationalist, intelligent guide, SEAMANIA is a life coach. Housed in your own digital aquarium, your SEAMAN AI reduces stress, combats loneliness, and guides humanity towards a brighter future. Imagine an AI companion that doesn’t just respond but truly understands, entertains, and supports you—blending humor, sarcasm, and wisdom.

SEAMANIA

SEAMANIA is gaining traction as a high-volatility meme coin, with community members actively coordinating buying pressure and drawing comparisons to other recent rapid runners in the crypto space. Participants are heavily focused on the potential for massive percentage gains while debating the sustainability of the price action and the speculative nature of the asset.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS It&#39;s to be expected with increasing share price before REGAL FA readout and SLS-009 catalysts, but it&#39;s real shame there are these traders throwing price targets like this. 
 
Do whatever you want with your trades but don&#39;t make comments like this throwing out $6/$7 targets. 
 
There are 99.99% chances of REGAL success, and you can read through all the DD that provides this statistically accurate prediction.  Failure is a statistical impossibility. 
 
And if you&#39;ve looked at the DD and don&#39;t understand that, you&#39;re intentionally being ignorant, ignoring what is clear as day. 
 
Real upside from $5.50 a share is 5X to 29X.  I encourage everyone to hold through REGAL FA and buyout, as the strategic acquisition will be gigantic. 
 
Do whatever you want with your trades but don&#39;t try to downplay the upside.  And stop comparing SLS to any other biotech, it&#39;s an ignorant comparison.  This isn&#39;t &quot;binary,&quot; it&#39;s deep value given the margin of safety in the trial. 
 
Fortunes will be made with sizeable positions.

Slippin Jimmy RETURNS

Enrico Papke

Gediminas Karalius

🤠

YEHMINGZHU

Louise

Dr. Arogart

Federico

Mark Hansen

Stocktwits

Ehrenhardt

Emagen

Paulstoxk

Bennyterner

Teo Chee Chong

Alan

Webbie

Easy E

Paul Fields

Khari Knapp

F. S. Fetchet

mrittika1971

Spaceyboy

Chessdoc

John

johnychicago

Patrick

$SLS  For those that didn&#39;t realize, my question was sincere as I&#39;ve been a strong supporter of $SLS for over 2 years.  Bullish on every post...and get attacked for asking a simple question.   
 
Thanks for those that were cordial and shared their DD (regardless of side, they are all data points so thank you). 
 
For the $SLS &quot;can&#39;t miss&quot; bro pumpers, take a lesson from $ALT.   
 
For the $ALT low life&#39;s attacking any post I make because I exposed $ALT, thanks to continue to show I live rent free in your head.  
 
My first $SLS post - March 1, 2024...Bullish

StockTwits Web

SELLAS Life Sciences Group Inc

Altimmune Inc

The Legendary Mayor

 It's to be expected with increasing share price before REGAL FA readout and SLS-009 catalysts, but it's real shame there are these traders throwing price targets like this. 
 
Do whatever you want with your trades but don't make comments like this throwing out $6/$7 targets. 
 
There are 99.99% chances of REGAL success, and you can read through all the DD that provides this statistically accurate prediction.  Failure is a statistical impossibility. 
 
And if you've looked at the DD and don't understand that, you're intentionally being ignorant, ignoring what is clear as day. 
 
Real upside from $5.50 a share is 5X to 29X.  I encourage everyone to hold through REGAL FA and buyout, as the strategic acquisition will be gigantic. 
 
Do whatever you want with your trades but don't try to downplay the upside.  And stop comparing SLS to any other biotech, it's an ignorant comparison.  This isn't "binary," it's deep value given the margin of safety in the trial. 
 
Fortunes will be made with sizeable positions.

Deckers Outdoor Corp.

AMC Entertainment Holdings

Beyond Meat Inc

Corsair Gaming Inc

@yG19 most here know this penny flip, flips and flops like fish washed up and in with the shore….

Herda Christian

Roger Rabbit $5,56

Robert

 most here know this penny flip, flips and flops like fish washed up and in with the shore….

Gilead Sciences, Inc.

Bristol-Myers Squibb Co.

Merck & Co Inc

SPDR S&P Biotech ETF

Abbvie Inc

Forty Seven, Inc.

Abivax - ADR

6,700% ROI this quarter

@yG19 BioRich is strange... almost pathological, if you read through all his posts. How can he waste his time badmouthing something like ALT!? He probably just wants attention to promote VERU! Good luck with that!

 BioRich is strange... almost pathological, if you read through all his posts. How can he waste his time badmouthing something like ALT!? He probably just wants attention to promote VERU! Good luck with that!

SeaStar Medical Holding Corp

@yG19 Greetings.  I think you misread my post.  It was from 2 years ago and referenced the analyst PTs.  As you&#39;ll see on that post, $SLS was under a buck.  No PTs made then and no PTs made now.   
 
As for the 99.99% chance and your eager optimism, it&#39;s a flag.  Caused me to look.  You are posting solely to $SLS and have no Watchlist.  Not sure how good you are, but that&#39;s a flag as well.  Combined, they are a red flag.  
 
As for comparison to other bios, I was only referring the scammish vibe that was felt on the ALT board.  That&#39;s all.  Not even the same sectors.  But, unfortunately, your post supports the scammish vibe on $SLS.

Paul Nipkow

 Greetings.  I think you misread my post.  It was from 2 years ago and referenced the analyst PTs.  As you'll see on that post, 

 was under a buck.  No PTs made then and no PTs made now.   
 
As for the 99.99% chance and your eager optimism, it's a flag.  Caused me to look.  You are posting solely to 

 and have no Watchlist.  Not sure how good you are, but that's a flag as well.  Combined, they are a red flag.  
 
As for comparison to other bios, I was only referring the scammish vibe that was felt on the ALT board.  That's all.  Not even the same sectors.  But, unfortunately, your post supports the scammish vibe on 

Sanofi-Aventis

Viking Therapeutics Inc

Milestone Pharmaceuticals Inc

Inventiva - ADR

Fractyl Health Inc.

@yG19 mute this guy… he is a hired hack for shorts.  He blindly bashes with no DD.
Don’t waste an ounce of energy or thought to this guy
He is a looser

StockTwits for iOS

 mute this guy… he is a hired hack for shorts.  He blindly bashes with no DD.
Don’t waste an ounce of energy or thought to this guy
He is a looser

Ricko4

@yG19 IG19, excellent DD as always. I’ve had @Biorich blocked for ages because he’s a toxic joke, so I’m replying here in your thread. 🚫
It’s pathetic how this &#39;Dean&#39; copy-pasted your hard work and 99.9% stats just to act smart while calling $ALT investors &#39;low lives.&#39; Anyone with a brain knows Pemvidutide is a masterpiece molecule for liver health and muscle mass—something his parrot-brain clearly can&#39;t grasp. He’s a hypocritical gasbag who does zero original research and lives off your credit. Absolute loser. Real investors see right through his &#39;national sport&#39; of bashing value. Keep up the great work, IG

 IG19, excellent DD as always. I’ve had 

 blocked for ages because he’s a toxic joke, so I’m replying here in your thread. 🚫
It’s pathetic how this 'Dean' copy-pasted your hard work and 99.9% stats just to act smart while calling 

 investors 'low lives.' Anyone with a brain knows Pemvidutide is a masterpiece molecule for liver health and muscle mass—something his parrot-brain clearly can't grasp. He’s a hypocritical gasbag who does zero original research and lives off your credit. Absolute loser. Real investors see right through his 'national sport' of bashing value. Keep up the great work, IG